Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
https://www.zacks.com/stock/news/2287702/pfizer-pfe-phase-iii-dmd-gene-therapy-study-misses-goal?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2287702
Jun 13, 2024 - Pfizer's (PFE) phase III study, CIFFREO, fails to show improvement in motor function in ambulatory boys with DMD treated with its gene therapy fordadistrogene movaparvovec compared to placebo.
0
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
https://www.zacks.com/stock/news/2287530/pfizer-pfe-stock-declines-while-market-improves-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2287530
Jun 12, 2024 - Pfizer (PFE) closed at $27.66 in the latest trading session, marking a -1.32% move from the prior day.
0
Pfizer Inc. (PFE) CEO Albert Bourla presents at Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
https://seekingalpha.com/article/4698450-pfizer-inc-pfe-ceo-albert-bourla-presents-goldman-sachs-45th-annual-global-healthcare?source=feed_sector_transcripts
Jun 10, 2024 - Pfizer Inc. (NYSE:NYSE:PFE) Goldman Sachs 45th Annual Global Healthcare Conference June 10, 2024 11:20 AM ETCompany ParticipantsAlbert Bourla - Chairman and...
0
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
https://www.zacks.com/stock/news/2286092/moderna-mrna-submits-updated-covid-19-jab-to-fda-for-review?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2286092
Jun 10, 2024 - Moderna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19 variant JN.1 to the FDA for the upcoming vaccination season.
0
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
https://www.fool.com/investing/2024/06/08/3-stocks-with-mouthwatering-dividends-you-can-buy/?source=iedfolrf0000001
Jun 08, 2024 - These stocks offer great dividends and more.
0
2 Dividend Stocks Billionaires Are Buying: Should You?
https://www.fool.com/investing/2024/06/07/2-dividend-stocks-billionaires-are-buying-should/?source=iedfolrf0000001
Jun 07, 2024 - That's not a bad crowd to follow when investing in stocks.
0
2 High-Yield Dividend Stocks to Buy Right Now
https://www.fool.com/investing/2024/06/05/2-high-yield-dividend-stocks-to-buy-right-now/?source=iedfolrf0000001
Jun 05, 2024 - These two high-yield dividend stocks are top buys right now.
0
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
https://www.zacks.com/stock/news/2283551/fda-panel-to-consider-updating-covid-19-jabs-for-new-virus-strains?cid=CS-ZC-FT-analyst_blog|industry_focus-2283551
Jun 04, 2024 - An FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to target the WHO-recommended JN.1 variant or the KP.2 variant which is the currently dominating strain in the country.
0
GSK Stock Dips on Delaware Court Ruling for Zantac Litigation
https://www.zacks.com/stock/news/2282848/gsk-stock-dips-on-delaware-court-ruling-for-zantac-litigation?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2282848
Jun 03, 2024 - GSK shares decline more than 7% in pre-market trading on Monday in response to an unfavorable ruling by a state court in Delaware in the Zantac litigation.
0
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
https://www.zacks.com/stock/news/2282785/moderna-mrna-secures-fda-nod-for-mrna-based-rsv-vaccine?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2282785
Jun 03, 2024 - The RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.
0